Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 26, 2024 | EXO Biologics | $17.1M Series A | — | Belgian family offices, Founders, Noshaq |
| Jan 17, 2024 | PDC*line Pharma | $5.1M Other Equity | BioWin, Walloon Region | — |
| Dec 6, 2021 | PDC*line Pharma | $26.2M Grant / Series B | Sangwoo Lee | Alpha Holdings, Brain Asset Management, Hansongneotech, Noshaq, Sambrinvest, Fontaine François, Smart Korea UTC Bio-Healthcare Venture Fund, SRIW |
| Sep 30, 2021 | EsoBiotec | $7.0M Pre-Series A | — | Helena Pozios, Franssen Christina, Michel Briejer |
| Jan 23, 2018 | Univercells | $2.9M Grant | Walloon Region | — |
| Nov 30, 2015 | Bone Therapeutics | $3.2M Grant | Walloon Region | — |
| Nov 26, 2013 | Bioxodes | $3.5M Seed | — | European Regional Development Fund |
| Mar 28, 2012 | Promethera Biosciences | $31.4M Debt / Series B | — | ATMI, Boehringer Ingelheim, Financière Spin-off Luxembourgeoise, Life Sciences Research Partners, Mitsui & Co. Global Investment, Nivelinvest, Sambrinvest, Shire, Sopartec, SRIW, Vesalius Biocapital, VIVES Louvain Technology Fund |